Multiple sclerosis can be a debilitating condition. Help future pregnant women, doctors, and researchers understand the safety of medications that can provide some relief.
You may be eligible if you are:
*Please note: If you have taken certain multiple sclerosis medications (e.g., Gilenya®, Mayzent®, Ponvory™, Novantrone®, Mavenclad®) prior to or during pregnancy you may not be eligible to participate. The registry staff can help determine your eligibility if you have taken these medications.
Complete the Contact Request Form here and a registry staff member will contact you
Email the registry team with your contact information at: CRGZeposiaMSpregnancyregistry@thermofisher.com
Call the registry team toll-free at
1-877-301-9314
(hours of operation 8.30am – 5.00 pm EST)
ZEPOSIA® (ozanimod) is a prescription medicine made by Celgene Corporation, a Bristol-Myers Squibb Company, that is used to treat relapsing forms of multiple sclerosis in adults.
Specifically, it is for the treatment of:
Future pregnant women with multiple sclerosis, doctors, and researchers can benefit from the information you provide to the registry.
If you are eligible and would like to participate, you will be asked to:
You and your healthcare provider(s) will provide information to the registry about your pregnancy and your baby’s health up to 1 year of age. This information can be provided by completing paper forms or via a short phone interview with one of the registry staff members. Only information normally documented in your medical record will be collected.
If you participate, there will be:
If you are eligible and would like to participate, you will be asked to provide basic information about yourself (e.g. race, ethnicity, education, height, and weight) at enrollment.